Rapid introduction of oral antivirals for COVID-19: implementation of a test and treat program in four African countries
Introduction: Despite availability of approved oral antivirals like nirmatrelvir/ritonavir to treat COVID-19 in high-income countries since 2021, access to these drugs remains largely unavailable across the African continent.Ghana, Malawi, Rwanda and Zambia, all members of the COVID Treatment QuickStart Consortium, leveraged existing infrastructure